| Sterling Biotech has reported a standalone total income from operations of Rs 108.02 crore and a net loss of Rs 94.21 crore for the quarter ended Sep '15. Other income for the quarter was Rs 0.99 crore. | | For the quarter ended Sep 2014 the standalone total income from operations was Rs 173.76 crore and net loss was Rs 116.72 crore, and other income Rs 1.01 crore. | | Sterling Bio shares closed at 4.70 on November 09, 2015 (NSE) and has given -22.95% returns over the last 6 months and -44.05% over the last 12 months. |
|
| | Sterling Biotech | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Sep '15 | Jun '15 | | | Sep '14 | | Net Sales/Income from operations | 107.03 | 116.90 | | | 172.75 | | Other Operating Income | 0.99 | 1.19 | | | 1.01 | | Total Income From Operations | 108.02 | 118.08 | | | 173.76 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 63.59 | 79.71 | | | 212.49 | | Purchase of Traded Goods | -- | -- | | | -- | | Increase/Decrease in Stocks | 9.24 | -3.47 | | | -87.90 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 13.01 | 13.45 | | | 12.90 | | Depreciation | 70.21 | 70.17 | | | 63.82 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 7.32 | 7.03 | | | 8.51 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -55.34 | -48.81 | | | -36.06 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | -55.34 | -48.81 | | | -36.06 | | Interest | 84.12 | 82.17 | | | 128.58 | | P/L Before Exceptional Items & Tax | -139.46 | -130.98 | | | -164.64 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -139.46 | -130.98 | | | -164.64 | | Tax | -45.25 | -42.50 | | | -53.42 | | P/L After Tax from Ordinary Activities | -94.21 | -88.48 | | | -111.22 | | Prior Year Adjustments | -- | -- | | | -5.50 | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -94.21 | -88.48 | | | -116.72 | | Equity Share Capital | 27.20 | 27.20 | | | 27.20 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -3.46 | -3.25 | | | -4.09 | | Diluted EPS | -2.18 | -2.04 | | | -2.57 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -3.46 | -3.25 | | | -4.09 | | Diluted EPS | -2.18 | -2.04 | | | -2.70 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 13.55 | 13.55 | | | 13.55 | | Share Holding (%) | 49.82 | 49.82 | | | 49.82 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 5.08 | 5.08 | | | 5.08 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 55.94 | 55.94 | | | 55.94 | | - Per. of shares (as a % of the total Share Cap. of the company) | 18.68 | 18.68 | | | 18.68 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 4.00 | 4.00 | | | 4.00 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 44.06 | 44.06 | | | 44.06 | | - Per. of shares (as a % of the total Share Cap. of the company) | 14.71 | 14.71 | | | 14.71 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
